Develops biopharmaceutical products for the treatment of cardio metabolic and neurodegenerative diseases This is an ADR of a company whose stock trades outside of the U.S. as the symbol FP:GNFT.
$5.09 +0.09 (1.80%)
As of 03/01/2021 15:46:47 EST IEX book CBOE book
2021 © Stock Market MBA, Inc.